BRCA1 gene

Artists rendering of a DNA molecule

To help clinicians and patients obtain better information about the breast or ovarian cancer risks posed by specific mutations in the BRCA1 gene, Greg Findlay, an M.D./Ph.d.

September 12, 2018

A new scientific analysis of nearly 4,000 mutations deliberately engineered into the BRCA1 gene will immediately benefit people undergoing genetic testing for breast or ovarian cancer risk.

Subscribe to BRCA1 gene